Alkermes CEO Richard Pops to retire July 31, 2026; COO Blair Jackson named successor

Alkermes plc.

Richard Pops retires as CEO effective July 31, 2026, after 35-year tenure; will remain Chairman and Senior Advisor through Dec 31, 2026.
Blair Jackson, current EVP/COO, appointed CEO effective Aug 1, 2026; Jackson has over 25 years experience at Alkermes.
Pops receives $75k/month advisory retainer, pro-rated FY2026 bonus at target, $2.69M RSU grant vesting Dec 31, 2026, and $40k Chairman retainer.
Outstanding equity awards continue vesting post-retirement; post-termination exercise periods extended up to 21 months.
Company cites ~$1.5B annual revenue, ~2,000 employees, and alixorexton's Breakthrough Therapy designation for narcolepsy type 1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.